We are live on ! Find out more
TG

Tom Gayner Markel Group

AUM $13.1B
1-Year Est. Return 15.62%
 

Tom Gayner is the CEO of Markel Group and long-time steward of its public equity portfolio. Often compared to a smaller-scale Berkshire-style model, Markel combines insurance operations with a carefully selected book of common stocks. Gayner is known for a patient, owner-oriented philosophy and for writing clearly about compounding, culture, and long-term business ownership.

This Fund
S&P 500
This Quarter Est. Return
+5.84%
1 Year Est. Return
+15.62%
3 Year Est. Return
+68.04%
5 Year Est. Return
+83.51%
10 Year Est. Return
+378.4%
AUM
$4.44B
AUM Growth
+$290M
Cap. Flow
+$75.1M
Cap. Flow %
1.69%
Top 10 Hldgs %
43.32%
Holding
137
New
4
Increased
54
Reduced
–
Closed
4

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$10.8M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$10.7M
3
ADI icon
Analog Devices
ADI
+$8.55M
4
SRCL
Stericycle Inc
SRCL
+$6.83M
5
TXN icon
Texas Instruments
TXN
+$4.57M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$24.5M
2
LLTC
Linear Technology Corp
LLTC
+$12.8M
3
CSX icon
CSX Corp
CSX
+$5.03M
4
MJN
Mead Johnson Nutrition Company
MJN
+$2.29M

Sector Composition

Rank Sector Weight
1 Financials 31.38%
2 Consumer Discretionary 16.72%
3 Healthcare 11.82%
4 Industrials 10.55%
5 Communication Services 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BAX icon
126
Baxter International
BAX
$13.6B
$1.14M 0.03%
22,000
– –
BATRA icon
127
Atlanta Braves Holdings Series A
BATRA
$3.64B
$1.02M 0.02%
42,600
– –
BMY icon
128
Bristol-Myers Squibb
BMY
$137B
$544K 0.01%
10,000
– –
BKNG icon
129
Booking.com
BKNG
$158B
$356K 0.01%
5,000
– –
MRK icon
130
Merck
MRK
$376B
$356K 0.01%
5,869
– –
LILA icon
131
Liberty Latin America Class A
LILA
$1.66B
$327K 0.01%
22,990
– –
NVS icon
132
Novartis
NVS
$302B
$275K 0.01%
4,129
– –
HEI icon
133
HEICO Corp
HEI
$49.6B
$262K 0.01%
7,324
– –
CSX icon
134
CSX Corp
CSX
$95.6B
– –
-420,000
Closed -$5.03M
ORCL icon
135
Oracle
ORCL
$422B
– –
-638,000
Closed -$24.5M
MJN
136
DELISTED
Mead Johnson Nutrition Company
MJN
– –
-32,300
Closed -$2.29M
LLTC
137
DELISTED
Linear Technology Corp
LLTC
– –
-206,000
Closed -$12.8M
2 3 4 5
6

Similar funds

BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
GLA
Great Lakes Advisors Chicago, Illinois $13.1B AUM 34.09% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $13.1B AUM 19.56% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Tom Gayner's Q1 2017 Portfolio in Review

As of Q1 2017, Tom Gayner held 137 positions worth $4.44B, up 7% from $4.15B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Tom Gayner's Q1 2017 filing shows 4 new, 54 increased and 4 closed positions. Its largest new stake was Healthcare Services Group: 55,000 shares worth $2.37M. The largest sale was Oracle, an estimated $24.5M.

By sector, the portfolio is most concentrated in Financials at 31% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Tom Gayner's largest Q1 2017 buy was Healthcare Services Group: 55,000 shares worth $2.37M.
  • Tom Gayner added most to Amazon in Q1 2017, an estimated $10.8M increase.
  • Tom Gayner fully exited Oracle in Q1 2017, selling an estimated $24.5M.
  • Tom Gayner's ten largest holdings make up 43% of its $4.44B portfolio in Q1 2017.
  • Tom Gayner opened 4 new positions and closed 4 in Q1 2017.
  • Tom Gayner's portfolio value rose 7% quarter-over-quarter to $4.44B.

Based on Markel Group's 13F filing for Q1 2017, filed 28 Apr 2017.